Assessing the potential of HTA to inform resource allocation decisions in low-income settings: The case of Malawi.
Malawi
health technology assessment (HTA)
healthcare decision making
low- and middle-income countries
resource allocation in health care
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2022
2022
Historique:
received:
03
08
2022
accepted:
03
10
2022
entrez:
17
11
2022
pubmed:
18
11
2022
medline:
22
11
2022
Statut:
epublish
Résumé
Health technology assessment (HTA) offers a set of analytical tools to support health systems' decisions about resource allocation. Although there is increasing interest in these tools across the world, including in some middle-income countries, they remain rarely used in low-income countries (LICs). In general, the focus of HTA is narrow, mostly limited to assessments of efficacy and cost-effectiveness. However, the principles of HTA can be used to support a broader series of decisions regarding new health technologies. We examine the potential for this broad use of HTA in LICs, with a focus on Malawi. We develop a framework to classify the main decisions on health technologies within health systems. The framework covers decisions on identifying and prioritizing technologies for detailed assessment, deciding whether to adopt an intervention, assessing alternative investments for implementation and scale-up, and undertaking further research activities. We consider the relevance of the framework to policymakers in Malawi and we use two health technologies as examples to investigate the main barriers and enablers to the use of HTA methods. Although the scarcity of local data, expertise, and other resources could risk limiting the operationalisation of HTA in LICs, we argue that even in highly resource constrained health systems, such as in Malawi, the use of HTA to support a broad range of decisions is feasible and desirable.
Identifiants
pubmed: 36388387
doi: 10.3389/fpubh.2022.1010702
pmc: PMC9650047
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1010702Informations de copyright
Copyright © 2022 Ramponi, Twea, Chilima, Nkhoma, Kazanga Chiumia, Manthalu, Mfutso-Bengo, Revill, Drummond and Sculpher.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Int J Technol Assess Health Care. 2020 Aug 13;:1-6
pubmed: 32787995
F1000Res. 2020 May 14;9:364
pubmed: 32595957
Int J Technol Assess Health Care. 2019 Jan;35(1):64-68
pubmed: 30938278
Soc Sci Med. 2018 Mar;200:59-64
pubmed: 29421472
Glob Health Action. 2017;10(1):1370194
pubmed: 29035166
Value Health. 2016 Mar-Apr;19(2):138-44
pubmed: 27021746
Insights Imaging. 2022 Mar 26;13(1):58
pubmed: 35347470
Value Health. 2020 Feb;23(2):139-150
pubmed: 32113617
J Int AIDS Soc. 2019 Mar;22 Suppl 1:e25243
pubmed: 30907498
Front Pharmacol. 2020 Feb 21;11:15
pubmed: 32153393
Value Health. 2019 Jan;22(1):13-20
pubmed: 30661627
Int J Technol Assess Health Care. 2015;31(6):442-8
pubmed: 26831815
Rev Panam Salud Publica. 2017 Dec 26;41:e165
pubmed: 31384277
Int J Technol Assess Health Care. 2020 Apr;36(2):173-178
pubmed: 32312340
Med Decis Making. 2008 Jan-Feb;28(1):21-32
pubmed: 18263559
BMC Health Serv Res. 2015 Mar 31;15:126
pubmed: 25889757
Int J Technol Assess Health Care. 2020 Oct;36(5):500-507
pubmed: 32981532
Value Health. 2020 Jan;23(1):17-24
pubmed: 31952668
Health Econ. 2020 Aug;29(8):945-954
pubmed: 32412153
AIDS Behav. 2018 Feb;22(2):560-568
pubmed: 28699017
Int J Technol Assess Health Care. 2020 Jun;36(3):187-190
pubmed: 32398176
Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):39-44
pubmed: 26499414
Radiology. 2005 Feb;234(2):415-22
pubmed: 15670999
J Infect Dis. 2015 Aug 15;212(4):570-7
pubmed: 25767214
Lancet Glob Health. 2020 Feb;8(2):e276-e287
pubmed: 31981557
Cost Eff Resour Alloc. 2018 Nov 09;16(Suppl 1):43
pubmed: 30455602
Int J Health Policy Manag. 2020 Jan 01;9(1):27-33
pubmed: 31902192
Int J Technol Assess Health Care. 2020 Apr;36(2):80-86
pubmed: 31402790
BMC Med. 2015 Sep 16;13:224
pubmed: 26377409
Health Policy Plan. 2018 Apr 1;33(3):456-463
pubmed: 29309581
Eur J Health Econ. 2018 Jul;19(6):769-774
pubmed: 29209854
Curr Opin Infect Dis. 2018 Feb;31(1):14-24
pubmed: 29232277
PLoS One. 2014 Jan 08;9(1):e84824
pubmed: 24416293
Value Health. 2018 Apr;21(4):394-397
pubmed: 29680094
Value Health Reg Issues. 2018 Sep;16:61-65
pubmed: 30195092
PLoS One. 2018 Jan 2;13(1):e0190283
pubmed: 29293611
Value Health Reg Issues. 2017 Dec;14:20-27
pubmed: 29254537
Int J Technol Assess Health Care. 2007 Summer;23(3):310-5
pubmed: 17579932
BMJ Glob Health. 2018 Apr 9;3(2):e000607
pubmed: 29662689
BMC Public Health. 2020 Jan 15;20(1):66
pubmed: 31941479
Health Technol Assess. 2012;16(46):1-323
pubmed: 23177626
J Int AIDS Soc. 2019 Jul;22(7):e25325
pubmed: 31287620
F1000Res. 2017 Dec 11;6:2119
pubmed: 29333249
Value Health Reg Issues. 2020 Dec;23:6-12
pubmed: 31999988
Health Res Policy Syst. 2014 Dec 02;12:66
pubmed: 25466570
Int J Technol Assess Health Care. 2020;36(1):29-33
pubmed: 31944173
MDM Policy Pract. 2017 Feb 01;2(1):2381468317691766
pubmed: 30288415
Glob Health Action. 2018;11(1):1527556
pubmed: 30326795